4-Sulfonamide-phenylhydrazine hydrochloride | CAS:27918-19-0

We serve 4-Sulfonamide-phenylhydrazine hydrochloride CAS:27918-19-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Sulfonamide-phenylhydrazine hydrochloride

Chemical Name:4-Sulfonamide-phenylhydrazine hydrochloride
CAS.NO:27918-19-0
Synonyms:4-Sulfonamide-phenylhydrazine hydrochloride
p-Sulfonamidophenylhydrazine
4-Aminosulfonylphenylhydrazine hydrochloride
p-sulfoamidophenylhydrazine hydrochloride
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 434.7±47.0 °C at 760 mmHg
Melting Point 180ºC
Molecular Formula C6H9N3O2S
Molecular Weight 187.220
Flash Point 216.7±29.3 °C
 
Specification:
Appearance:Off-white to yellow or orange crystalline powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Celecoxib(CAS:169590-42-5).



Contact us for information like 4-Sulfonamide-phenylhydrazine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-sulfoamidophenylhydrazine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Sulfonamide-phenylhydrazine hydrochloride Use and application,4-Aminosulfonylphenylhydrazine hydrochloride technical grade,usp/ep/jp grade.


Related News: At a national conference on TCM last October, Xi urged experts and officials to carry on and innovate the fine elements in TCM and underlined efforts to promote it internationally, Xinhua reported at the time.Chloroiodomethane manufacturer At a national conference on TCM last October, Xi urged experts and officials to carry on and innovate the fine elements in TCM and underlined efforts to promote it internationally, Xinhua reported at the time.2-Chloro-4-fluorobenzoic acid supplier The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.3-Nitro-4,5-dihydroxybenzaldehyde vendor There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.